AC Immune SA reports results for the quarter ended in December - Earnings Summary

AC Immune SA

16/03/2023 12:01

* AC Immune SA  ACIU.OQ  reported a quarterly adjusted loss
of 23
rappen​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 25 rappen per share.
    * Revenue was CHF1.00 thousand​; analysts expected CHF1.60
million. 
    * AC Immune SA's reported EPS for the quarter was a loss
of 23
rappen​.
    * The mean earnings estimate of analysts had fallen by
about 10.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AC Immune SA shares had risen by 12.7% this quarter.
    * The company reported a quarterly loss of CHF18.75 million.
    * Wall Street's median 12-month price target for AC Immune
SA is
$9.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 12:01 p.m. UTC. ​All figures in Swiss francs unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.25          -0.23          Beat
 Sep. 30 2022      -0.24          -0.16          Beat
 Jun. 30 2022      -0.23          -0.23          Met
 Mar. 31 2022      -0.22          -0.23          Missed